How to Read a Peptide COA

A lab-focused guide to interpreting certificates of analysis.

A Certificate of Analysis (COA) is more than a pass or fail sheet. It is the primary record that connects a peptide lot to its identity, purity, and key quality attributes that can influence reproducibility in analytical or in vitro work. This guide explains the most common COA fields, how they are generated, and what to look for when comparing lots.

A strong COA links a specific lot to clear methods, acceptance criteria, and traceable results.

What a COA is (and why it matters)

A COA is a lot-specific document that summarizes analytical results for a material. In peptide research, COAs typically report identity and purity, and may also include content, counterion, water, residual solvents, and bioburden indicators. These attributes affect signal-to-noise, background effects, and experiment-to-experiment consistency. Batch purity can vary between lots, and by-products from synthesis can differ in structure and proportion — making lot-level documentation essential for reproducible research workflows. [PubMed: 18604941]

Key COA sections you should expect

• Product and lot details: product name, sequence, molecular weight (theoretical), lot number, manufacturing date, and retest date (if used).
• Methods: the analytical techniques used (for example HPLC/UPLC, LC-MS, MALDI-TOF, Karl Fischer) and any reference methods or internal SOPs.
• Results vs acceptance criteria: measured values paired with specification limits.
• Approvals and traceability: analyst sign-off, QA review, and document control identifiers.

Purity: what HPLC can and cannot tell you

Purity is commonly reported as an HPLC area percentage using UV detection, typically at 210–220 nm where the peptide backbone absorbs strongly. It is a useful comparative metric, but it depends on method conditions — column chemistry, gradient, detection wavelength, and integration parameters. When comparing vendors or lots, confirm that the method and reporting approach are comparable. Reversed-phase HPLC has been the standard analytical method for peptide purity determination for decades, enabling separation based on hydrophobicity and quantification of impurity profiles. [PubMed: 18604941] [PubMed: 22516680]

• Look for: chromatogram images, integration parameters, and a stated wavelength.
• Watch for: “purity” reported without method context, or purity that changes significantly across methods.

Identity: confirming you received the intended peptide

Identity is typically supported by mass spectrometry (MS). A COA may list observed m/z values, deconvoluted mass, or a match to theoretical mass. Electrospray ionization LC-MS is commonly used to confirm peptide mass and verify amino acid sequence, with standard adduct ions such as sodium or potassium adducts expected at low intensity alongside the primary [M+H]+ peak. Identity confirmation is essential when peptides share similar sequences or when truncations — a common synthesis byproduct — are present. An unexpected major peak at an unrelated mass warrants further investigation with MS/MS. [PMC: 10338602]

Content and salt form: why it impacts calculations

Some COAs report peptide content (assay) as a percentage. Others specify the counterion (for example acetate or trifluoroacetate) and may list the counterion percentage. Salt form and content influence the calculated amount of peptide present per mass of material — a critical consideration for analytical preparation and stoichiometry in assays. Published analytical frameworks describe a mass balance approach where peptide content, counterion, and water content should sum to 100%, providing a check against undetected impurities. [PMC: 10338602]

Common “extra” quality attributes (and when you should care)

• Water content (Karl Fischer): important for hygroscopic peptides and long storage. Peptides with high proportions of basic amino acids (Arg, Lys, His) are particularly prone to moisture uptake due to salt formation at free functionalities.
• Residual solvents: relevant if a lab requires compliance with internal solvent limits. Solvents used during synthesis can persist in the final lyophilized product and are quantified separately from peptide purity.
• Endotoxin or bioburden indicators: critical for cell-based assays sensitive to inflammatory artifacts — even trace lipopolysaccharide contamination can alter cytokine readouts and confound functional results.

Quick COA review checklist

• Lot number on the COA matches the label and invoice.
• Methods are stated (not just the results).
• Identity supported by MS with a clear match to theoretical mass.
• Purity reported with enough context to compare across lots.
• Counterion, content, or assay information included when relevant to your workflow.

How to compare COAs across lots

When you move between lots, keep a small internal record of COA attributes and experimental outcomes. If a result shifts, this traceability can help you identify whether the change is methodological, environmental, or material-related. Validated HPLC methods applied consistently across lots provide the most reliable basis for direct comparison — method differences between suppliers or between runs can introduce variability independent of actual product quality. [PubMed: 22516680]

References

1. Mant CT, Hodges RS. HPLC analysis and purification of peptides. Methods in Molecular Biology. 2008;527. [PubMed: 18604941]
2. Salim MM, Bhatt DL, Bhatt D, et al. Development and validation of an HPLC/UV assay for separation and quantification of peptide antigens from a liposomal vaccine delivery platform. Journal of Pharmaceutical and Biomedical Analysis. 2012;63:54–60. [PubMed: 22516680]
3. Strickler J, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Journal of Pharmaceutical Sciences. 2023. [PMC: 10338602]

For Research Use Only. The information in this article is intended for qualified researchers and laboratory professionals. It does not constitute medical, clinical, or veterinary advice, and should not be interpreted as guidance for human use of any kind. Read our RUO Policy